In this study, we observed a remarkable upregulation of KDM1A in NAFLD and proved that KDM1A exacerbates hepatic steatosis and inflammation in NAFLD via increasing chromatin accessibility. Here, KDM1A is linked to metabolic dysfunction-associated steatotic liver disease.